MELD 3.0 for adolescent liver transplant candidates.
Allison J KwongKe-You ZhangNoelle EbelAjitha MannalitharaW Ray KimPublished in: Hepatology (Baltimore, Md.) (2023)
The discriminative ability of MELD 3.0 to rank adolescents according to the risk of death within 90 days was robust. Although MELD 3.0 was initially developed and validated in adults, MELD 3.0 may also improve the prediction of waitlist mortality in adolescents and better represent their urgency for liver transplant.